Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2026 04:58 ET | Source: Shell plc

Transaction in Own Shares

Transaction in Own Shares 07 May, 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 07 May, 2026 it purchased the following number of Shares for cancellation. ...
May 07, 2026 22:10 ET | Source: Mobia Medical, Inc.

Mobia Medical Announces Pricing of Initial Public Offering

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI) (“Mobia Medical”), a commercial-stage medical device company redefining stroke recovery for survivors living with...
May 07, 2026 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Myriad Genetics will participate in The BofA Securities 2026 Health Care Conference and Goldman Sachs 47th Annual Global Healthcare Conference.
May 07, 2026 16:01 ET | Source: Denali Therapeutics Inc.

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

FDA approved AVLAYAH™ (tividenofusp alfa-eknm) for treatment of Hunter syndrome (MPS II) and as first medicine to leverage transferrin receptor to cross blood-brain barrierAVLAYAH launched in U.S....
May 07, 2026 15:00 ET | Source: Beacon Therapeutics (USA), Inc.

Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting

Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular sensitivity as measured by microperimetry.Laru-zova was...